ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,607.90
0.50%
S&P ASX All Technology
2,973.10
0.14%
Brent Oil
83.775
0.28%
US Dollar vs AUD
1.53047
-0.03%
Bitcoin
57,414.47
-1.41%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Celcuity Inc (CELC)

  7. Celcuity Inc (CELC) News

CELC Celcuity Inc

15.9499
0.1799 (1.14%)
02 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Celcuity Inc CELC NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
0.1799 1.14% 15.9499 08:00:01
Open Price Low Price High Price Close Price Previous Close
15.84 15.50 16.40 16.30 15.77
more quote information »

Recent News

Date Time Source Heading
04/4/202422:05GLOBECelcuity To Present at Upcoming Needham and Stifel Investor..
28/3/202407:01GLOBECelcuity Inc. Reports Fourth Quarter and Full Year 2023..
20/3/202422:05GLOBECelcuity Inc. Schedules Release of Fourth Quarter and Full..
06/3/202423:05GLOBECelcuity to Participate in Leerink Partners Global Biopharma..
28/2/202423:05GLOBECelcuity to Participate in Cowen’s 44th Annual Health Care..
24/2/202408:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202408:05GLOBECelcuity Announces First Patient Dosed in Phase 1b/2..
20/2/202423:05GLOBECelcuity Appoints Eldon Mayer as Chief Commercial Officer
16/2/202409:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202409:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202412:28EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
15/2/202408:05EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
10/2/202402:32EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/2/202409:15EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
23/12/202308:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/12/202302:34EDGAR2Form 144 - Report of proposed sale of securities
07/12/202300:30GLOBECelcuity Presents Preclinical Data on Therapeutic Effects of..
06/12/202309:25EDGAR2Form 8-K - Current report
02/12/202303:02GLOBECelcuity to Present Preclinical Data for Gedatolisib at the..
01/12/202308:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/11/202308:30EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
29/11/202316:15EDGAR2Form EFFECT - Notice of Effectiveness
23/11/202300:15EDGAR2Form S-3/A - Registration statement under Securities Act of..
23/11/202300:05GLOBECelcuity to Participate in the 6th Annual Evercore ISI..
14/11/202306:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202323:35EDGAR2Form 8-K - Current report
13/11/202323:05GLOBECelcuity Inc. Reports Third Quarter 2023 Financial Results..
06/11/202323:30GLOBECelcuity Inc. Schedules Release of Third Quarter 2023..
01/11/202322:05GLOBECelcuity To Present at Upcoming Stifel and Jefferies..
28/10/202307:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/10/202308:15EDGAR2Form 8-K - Current report
08/9/202306:05GLOBECelcuity to Host Virtual Science Day for Investors
02/9/202306:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/8/202300:58EDGAR2Form 144 - Report of proposed sale of securities
30/8/202306:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/8/202306:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/8/202307:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/8/202307:15EDGAR2Form 8-K - Current report
23/8/202306:05GLOBECelcuity Enters into a Clinical Trial Collaboration and..
23/8/202306:01GLOBECelcuity Announces Plan to Conduct Phase 1b/2 Clinical Trial..
12/8/202307:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/8/202306:10EDGAR2Form 8-K - Current report
11/8/202306:04GLOBECelcuity Inc. Reports Second Quarter 2023 Financial Results..
03/8/202321:30GLOBECelcuity Inc. Schedules Release of Second Quarter 2023..
31/7/202322:00GLOBECelcuity to Participate in the BTIG Virtual Biotechnology..

Your Recent History

NASDAQ
CELC
Celcuity
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved